Cerebral Trypanosomiasis in an Immunocompromised Patient: Case Report and Review of the Literature

World Neurosurg. 2019 Sep:129:225-231. doi: 10.1016/j.wneu.2019.05.260. Epub 2019 Jun 7.

Abstract

Background: We document a case of central nervous system infection with Trypanosoma cruzi.

Case description: An 88-year-old woman presented with altered mental status, right-sided weakness, and slurred speech. Her medical history was significant for methotrexate intake for rheumatoid arthritis, and she tested negative for human immunodeficiency virus. Magnetic resonance imaging of the brain showed bilateral thick and peripherally enhancing white matter lesions in the frontoparietal region with extensive surrounding vasogenic edema. A lumbar puncture revealed increased protein and lymphocytic pleocytosis, and needle biopsy highlighted brain necrosis, chronic inflammation, and numerous intracellular organisms suggestive of T. cruzi amastigotes. Despite treatment with benznidazole, the patient expired soon after presentation.

Conclusion: Chagas disease should be included in the differential diagnosis of an immunocompromised patient presenting with a central nervous system mass, meningoencephalitis, or focal neurologic signs.

Keywords: Benznidazole; Chagas disease; Kinetoplasts; Trypanosoma cruzi.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged, 80 and over
  • Arthritis, Rheumatoid / drug therapy
  • Chagas Disease / immunology*
  • Female
  • Humans
  • Immunocompromised Host*
  • Immunosuppressive Agents / adverse effects
  • Meningoencephalitis / immunology*
  • Methotrexate / adverse effects

Substances

  • Immunosuppressive Agents
  • Methotrexate